IART Q1 2017 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$259M+9.2% YoY

Gross Profit

$172M66.5% margin

Operating Income

$10M3.9% margin

Net Income

$6M2.5% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$20M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.2B

Stockholders' Equity

$852M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$259M	$237M	+9.2%
Gross Profit	$172M	$152M	+13.2%
Operating Income	$10M	$22M	-55.0%
Net Income	$6M	$12M	-45.1%

Revenue Segments

Specialty Surgical Solutions

$156M60%

Orthopedics and Tissue Technologies

$102M40%

Geographic Segments

UNITED STATES

$201M78%

Europe

$29M11%

Rest Of World

$29M11%